Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5384)
All Articles published online
|
Publishing Process of This Article
|
May 6, 2021 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang Z, Lin Y, Duan XW, Hang HY, Zhang X, Li LL. Misdiagnosed dystrophic epidermolysis bullosa pruriginosa: A case report. World J Clin Cases 2021; 9(13): 3090-3094 [PMID: 33969095 DOI: 10.12998/wjcc.v9.i13.3090] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i13/3090.htm |
| Number | Citing Articles |
| 1 |
Fengming Jia, Qing Zhao, Peidian Shi, Hong Liu, Furen Zhang. Dupilumab: Advances in the off‐label usage ofIL4/IL13antagonist in dermatoses. Dermatologic Therapy 2022; 35(12) doi: 10.1111/dth.15924
|
| 2 |
D. Darbord, G. Hickman, N. Pironon, C. Barbieux, M. Bonnet‐des‐Claustres, M. Titeux, S. Miskinyte, F. Cordoliani, M.D. Vignon‐Pennamen, R. Amode, A. Hovnanian, E. Bourrat. Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity. Journal of the European Academy of Dermatology and Venereology 2022; 36(1): 133 doi: 10.1111/jdv.17671
|